Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec 3:12:798674.
doi: 10.3389/fphar.2021.798674. eCollection 2021.

Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic

Jia-Bo Wang  1 , Adolfo Andrade-Cetto  2 , Javier Echeverria  3 , Jon Wardle  4 , Hung-Rong Yen  5 , Michael Heinrich  6
Affiliations
Editorial

Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic

Jia-Bo Wang et al. Front Pharmacol. .
No abstract available

Keywords: COVID-19; adjuvant therapies; clinical study; ethnopharmacology; mechanism study; systematic review; traditional medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
COVID-19 papers focusing on different local and traditional medical systems (TMs) (A) in PubMed. and (B) represented in this research topic.
FIGURE 2
FIGURE 2
Publication on TM associated with COVID-19.
See this image and copyright information in PMC

Comment on

  • Editorial on the Research Topic Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic

References

    1. Adeloye D., Elneima O., Daines L., Poinasamy K., Quint J. K., Walker S., et al. (2021). The Long-Term Sequelae of COVID-19: an International Consensus on Research Priorities for Patients with Pre-existing and New-Onset Airways Disease. Lancet Respir. Med., 34416191. 10.1016/S2213-2600(21)00286-1 - DOI - PMC - PubMed
    1. Ai Z., Zhou S., Li W., Wang M., Wang L., Hu G., et al. (2020). "Fei Yan No. 1" as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study. Front. Pharmacol. 11, 581277. 10.3389/fphar.2020.581277 - DOI - PMC - PubMed
    1. Ayatollahi S. A., Sharifi-Rad J., Tsouh Fokou P. V., Mahady G. B., Ansar Rasul Suleria H., Krishna Kapuganti S., et al. (2021). Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection. Front. Pharmacol. 12, 575877. 10.3389/fphar.2021.575877 - DOI - PMC - PubMed
    1. Bao L., Deng W., Huang B., Gao H., Liu J., Ren L., et al. (2020). The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice. Nature 583, 830–833. 10.1038/s41586-020-2312-y - DOI - PubMed
    1. Benarba B., Pandiella A. (2020). Medicinal Plants as Sources of Active Molecules against COVID-19. Front. Pharmacol. 11, 1189. 10.3389/fphar.2020.01189 - DOI - PMC - PubMed

Publication types

LinkOut - more resources